title: Application of multianalyte microphysiometry to characterize macrophage metabolic responses to oxidized LDL and effects of an apoA-1 mimetic.
abstract: Although the interaction of macrophages with oxidized low density liopoprotein (oxLDL) is critical to the pathogenesis of atherosclerosis, relatively little is known about their metabolic response to oxLDL. Our development of the multianalyte microphysiometer (MAMP) allows for simultaneous measurement of extracellular metabolic substrates and products in real-time. Here, we use the MAMP to study changes in the metabolic rates of RAW-264.7 cells undergoing respiratory burst in response to oxLDL. These studies indicate that short duration exposure of macrophages to oxLDL results in time-dependent increases in glucose and oxygen consumption and in lactate production and extracellular acidification rate. Since apolipoprotein A-I (apoA-I) and apoA-I mimetics prevent experimental atherosclerosis, we hypothesized that the metabolic response of the macrophage during respiratory burst can be modulated by apoA-I mimetics. We tested this hypothesis by examining the effects of the apoA-I peptide mimetic, L-4F, alone and complexed with 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC) on the macrophage metabolic response to oxLDL. L-4F and the DMPC/L-4F complexes attenuated the macrophage respiratory burst in response to oxLDL. The MAMP provides a novel approach for studying macrophage ligand-receptor interactions and cellular metabolism and our results provide new insights into the metabolic effects of oxLDL and mechanism of action of apoA-I mimetics.
authors: Department of Chemistry, Vanderbilt University, VU Station B, Nashville, TN 37235-1822, USA.
authors: Danielle W
authors: DW
authors: Kimmel
authors: William P
authors: WP
authors: Dole
authors: David E
authors: DE
authors: Cliffel
mesh_terms: D000818:Animals; D016632:Apolipoprotein A-I / Q000494:pharmacology*; D050197:Atherosclerosis / Q000378:metabolism; D040761:Biomimetic Materials / Q000494:pharmacology*; D002460:Cell Line; D005947:Glucose / Q000378:metabolism; D019344:Lactic Acid / Q000096:biosynthesis; D008077:Lipoproteins, LDL / Q000494:pharmacology*; D008264:Macrophages / Q000187:drug effects* / Q000378:metabolism; D051379:Mice; D010100:Oxygen / Q000378:metabolism; D010455:Peptides / Q000494:pharmacology*; D011199:Potentiometry / Q000379:methods*
chemical_list: D016632:Apolipoprotein A-I; C472885:L-4F peptide; D008077:Lipoproteins, LDL; D010455:Peptides; C099252:oxidized low density lipoprotein; D019344:Lactic Acid; D005947:Glucose; D010100:Oxygen